Press Releases

• Cyxone appoints Carl-Magnus Högerkorp as permanent CEO

  13 Dec, 2022 13:10 CET
  Regulatory

• Cyxone receive ethical and regulatory approval from Hungary to start clinical Phase 2b study in RA

  1 Dec, 2022 10:56 CET

• Nomination committee appointed for Cyxone Annual General Meeting 2023

  8 Nov, 2022 13:35 CET

• Interim Report 1 January to 30 September 2022

  27 Oct, 2022 08:30 CEST
  Regulatory

• Cyxone presents T20K program at the ECTRIMS conference

  26 Oct, 2022 10:57 CEST